Curie Capital

Curie Capital is a life science focused venture capital firm founded in 2018. It is a new and dynamic investment fund with a personal touch. Curie Capital is based in Amsterdam and invests in early stage companies with talented teams and exciting science and technology. The founding partners Mariette van der Velden and Han de Groot both have extensive experience in investing, entrepreneurship and managing companies across the full life cycle from startup to (public) exit. The partners leverage their complementary skills and network for the success of their portfolio companies.

Curie Capital, established in 2018 and headquartered in United States, North America., specializes in Early Stage Venture, Seed investments across Biotechnology, Health Care, Therapeutics, Information Technology, Financial Services, Venture Capital, Life Science, CleanTech, Finance, Medical. Their recent investments include Flindr Therapeutics, V-Bio Ventures, BOM, Qbic Fund, Swanbridge Capital. The highest investment round they participated in was $5.6B. Among their most notable exits are Flindr Therapeutics and V-Bio Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.